We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
6426
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$0 ﹤0.01%
27
CDAQ
6427
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
-90
Closed -$1K
WESTW
6428
DELISTED
Westrock Coffee Company Warrants
WESTW
$0 ﹤0.01%
88
RBCP
6429
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
-441
Closed -$45K
GHSI
6430
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$0 ﹤0.01%
1
-898
-100% -$5.96K
HMNF
6431
DELISTED
HMN Financial Inc
HMNF
-358
Closed -$8K
HHGC
6432
DELISTED
HHG Capital Corporation Ordinary Shares
HHGC
$0 ﹤0.01%
43
AUGX
6433
DELISTED
Augmedix, Inc. Common Stock
AUGX
$0 ﹤0.01%
105
-2,745
-96% -$4.48K
ASTSW
6434
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$0 ﹤0.01%
182
BACA
6435
DELISTED
Berenson Acquisition Corp. I
BACA
-10
Closed
MKFG.WS
6436
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$0 ﹤0.01%
100
FAM
6437
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
-130
Closed -$1K
VLD.WS
6438
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$0 ﹤0.01%
17
HIPO.WS
6439
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$0 ﹤0.01%
124
CLOE
6440
DELISTED
Clover Leaf Capital Corp. Class A Common Stock
CLOE
-138
Closed -$1K
CLOEU
6441
DELISTED
Clover Leaf Capital Corp. Unit
CLOEU
$0 ﹤0.01%
9
TLIS
6442
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$0 ﹤0.01%
+35
New +$298
MRDB
6443
DELISTED
MariaDB plc
MRDB
-3
Closed
ASXC
6444
DELISTED
Asensus Surgical, Inc.
ASXC
$0 ﹤0.01%
262
MMAT
6445
DELISTED
Meta Materials Inc. Common Stock
MMAT
$0 ﹤0.01%
12
-10
-45% -$777
FEXD
6446
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
$0 ﹤0.01%
+3
New +$31
MACA
6447
DELISTED
Moringa Acquisition Corp Class A Ordinary Shares
MACA
-84
Closed -$1K
HEWG
6448
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
-1,771
Closed -$48K
IMAQ
6449
DELISTED
International Media Acquisition Corp. Class A Common Stock
IMAQ
-387
Closed -$4K
KRNL
6450
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
-108
Closed -$1K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.